Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
about
Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profilingβ-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.Increased liver carcinogenesis and enrichment of stem cell properties in livers of Dickkopf 2 (Dkk2) deleted mice.Newer treatments for advanced hepatocellular carcinoma.Pathways and targets in hepatocellular carcinoma.Prevention of recurrence after curative treatment for hepatocellular carcinoma.Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPARSorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathwayHepatocellular carcinoma in 2011 and beyond: from the pathogenesis to molecular targeted therapy.Real-life clinical practice with sorafenib in advanced hepatocellular carcinoma: a single-center experience.Ursolic Acid-Induced Apoptosis via Regulation of the PI3K/Akt and MAPK Signaling Pathways in Huh-7 Cells
P2860
Q33718695-414E4358-D3AA-4628-9185-43D9438B4494Q34326514-6B906ABC-62CB-409D-A531-F92AF9117C05Q34483561-1FB082FC-FB06-4E04-9BC3-68D1AB689781Q34531550-5BC6A12B-5AD5-4115-B0F1-8AB29682D0E5Q37301702-609D6F79-AF54-48A2-A6C3-C358148EB3EBQ37642185-0C0BCF37-7B2D-4FB4-89EA-F1F2B905E09FQ38062022-E1EC3352-F81B-41C7-A67B-8406325C33D9Q38070128-0588A662-36AD-4765-897F-7B0C2281E3F5Q38891038-0700AF1C-3923-4320-A299-B4DFA503B0DEQ39929763-8791548D-4116-4AB4-AA7A-9CB7679B7F32Q41623567-03974E5D-9EDE-43E5-BE46-AA3CF43D54A4Q43047099-5704DB52-DCE9-4330-8D81-27625CEC7F78Q51285944-53BCC021-A915-46DE-8FDA-4D5E0721F62BQ58697443-2A3C1F4D-C533-4630-9D04-2E37FAFD1CAD
P2860
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
@en
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
@nl
type
label
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
@en
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
@nl
prefLabel
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
@en
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
@nl
P2860
P356
P1433
P1476
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
@en
P2860
P304
P356
10.1159/000327562
P577
2011-08-09T00:00:00Z